Cortexyme Inc (NASDAQ:CRTX)

North American company
add to virtual portfolio
trade
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - CRTX

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - CRTX

  • Market Cap$1.486bn
  • SymbolNASDAQ:CRTX
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINUS22053A1079

Company Profile

Cortexyme Inc is a clinical-stage biopharmaceutical company developing a disease-modifying therapeutic approach to treat Alzheimer's and other degenerative diseases. Its approach is based on the seminal discovery of the presence of Porphyromonas gingivalis or P. gingivalis, and its secreted toxic virulence factor proteases called gingipains. The company operates in only one reportable segment that is developing and commercializing therapeutics.

Latest CRTX news

Currently there for this company. Visit our news hub for other news .